Fig. 23.5 Crystal structure of the inhibitor cyclotheonamide A with thrombin. The inhibitor forms a covalent bond to the catalytic serine with its α-keto group to form a hemiketal structure. The now negatively charged oxygen is stabilized by two hydrogen bonds in an oxyanion hole.